Revance Therapeutics Statistics
Total Valuation
JAKKS Pacific has a market cap or net worth of $183.03 million. The enterprise value is $201.12 million.
| Market Cap | 183.03M |
| Enterprise Value | 201.12M |
Important Dates
The last earnings date was Thursday, July 24, 2025, after market close.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
JAKKS Pacific has 11.15 million shares outstanding. The number of shares has increased by 7.93% in one year.
| Current Share Class | 11.15M |
| Shares Outstanding | 11.15M |
| Shares Change (YoY) | +7.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.91% |
| Owned by Institutions (%) | 53.27% |
| Float | 8.93M |
Valuation Ratios
The trailing PE ratio is 4.91 and the forward PE ratio is 6.55.
| PE Ratio | 4.91 |
| Forward PE | 6.55 |
| PS Ratio | 0.27 |
| Forward PS | 0.46 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 4.62 |
| P/OCF Ratio | 3.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.55, with an EV/FCF ratio of 5.08.
| EV / Earnings | 5.23 |
| EV / Sales | 0.29 |
| EV / EBITDA | 3.55 |
| EV / EBIT | 4.30 |
| EV / FCF | 5.08 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.71 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 1.42 |
| Interest Coverage | 47.01 |
Financial Efficiency
Return on equity (ROE) is 17.78% and return on invested capital (ROIC) is 11.33%.
| Return on Equity (ROE) | 17.78% |
| Return on Assets (ROA) | 7.16% |
| Return on Invested Capital (ROIC) | 11.33% |
| Return on Capital Employed (ROCE) | 16.38% |
| Revenue Per Employee | $1.01M |
| Profits Per Employee | $56,556 |
| Employee Count | 680 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 7.36 |
Taxes
In the past 12 months, JAKKS Pacific has paid $8.21 million in taxes.
| Income Tax | 8.21M |
| Effective Tax Rate | 17.59% |
Stock Price Statistics
The stock price has decreased by -20.10% in the last 52 weeks. The beta is 1.19, so JAKKS Pacific's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -20.10% |
| 50-Day Moving Average | 19.89 |
| 200-Day Moving Average | 24.44 |
| Relative Strength Index (RSI) | 26.91 |
| Average Volume (20 Days) | 189,404 |
Short Selling Information
The latest short interest is 458,457, so 4.11% of the outstanding shares have been sold short.
| Short Interest | 458,457 |
| Short Previous Month | 445,176 |
| Short % of Shares Out | 4.11% |
| Short % of Float | 5.14% |
| Short Ratio (days to cover) | 3.46 |
Income Statement
In the last 12 months, JAKKS Pacific had revenue of $684.69 million and earned $38.46 million in profits. Earnings per share was $3.34.
| Revenue | 684.69M |
| Gross Profit | 231.83M |
| Operating Income | 46.83M |
| Pretax Income | 30.32M |
| Net Income | 38.46M |
| EBITDA | 56.67M |
| EBIT | 46.83M |
| Earnings Per Share (EPS) | $3.34 |
Balance Sheet
The company has $38.20 million in cash and $56.29 million in debt, giving a net cash position of -$18.09 million or -$1.62 per share.
| Cash & Cash Equivalents | 38.20M |
| Total Debt | 56.29M |
| Net Cash | -18.09M |
| Net Cash Per Share | -$1.62 |
| Equity (Book Value) | 236.74M |
| Book Value Per Share | 21.19 |
| Working Capital | 109.10M |
Cash Flow
In the last 12 months, operating cash flow was $50.68 million and capital expenditures -$11.09 million, giving a free cash flow of $39.59 million.
| Operating Cash Flow | 50.68M |
| Capital Expenditures | -11.09M |
| Free Cash Flow | 39.59M |
| FCF Per Share | $3.55 |
Margins
Gross margin is 33.86%, with operating and profit margins of 6.84% and 5.62%.
| Gross Margin | 33.86% |
| Operating Margin | 6.84% |
| Pretax Margin | 6.82% |
| Profit Margin | 5.62% |
| EBITDA Margin | 8.28% |
| EBIT Margin | 6.84% |
| FCF Margin | 5.78% |
Dividends & Yields
This stock pays an annual dividend of $1.00, which amounts to a dividend yield of 5.90%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 5.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.95% |
| Buyback Yield | -7.93% |
| Shareholder Yield | -2.03% |
| Earnings Yield | 21.01% |
| FCF Yield | 21.63% |
Analyst Forecast
The average price target for JAKKS Pacific is $41.75, which is 154.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.75 |
| Price Target Difference | 154.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 10, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 10, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
JAKKS Pacific has an Altman Z-Score of 2.85 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 6 |